Revolution Medicines Inc (RVMD)

04:46 AM

RVMD: Morgan Stanley Smith Barney lists 3,121 shares for sale (05/26/2026) - Stock Titan

04:46 AM

03:37 AM

Total equity of Revolution Medicines, Inc. – BIVA:RVMD - TradingView

03:37 AM

10:22 AM

Liquidity Mapping Around (RVMD) Price Events - Stock Traders Daily

10:22 AM

08:54 AM

Truist Assumes Coverage of Revolution Medicines (RVMD), Lifts PT - Insider Monkey

08:54 AM

May 25, 2026

Revolution Medicines, Inc. (RVMD) Stock Analysis: Biotechnology Innovator with 20.65% Potential Upside - DirectorsTalk Interviews

May 25, 2026

May 23, 2026

Total equity of Revolution Medicines, Inc. – BMV:RVMD - TradingView

May 23, 2026

May 23, 2026

Price to earnings ratio of Revolution Medicines, Inc. – BMV:RVMD - TradingView

May 23, 2026

May 23, 2026

Revolution Medicines, Inc. Balance Sheet – BMV:RVMD - TradingView

May 23, 2026

May 22, 2026

Revolution Medicines stock hits all-time high at 155.72 USD By Investing.com - Investing.com Nigeria

May 22, 2026

May 22, 2026

RVMD Initiated Coverage by BernsteinPrice Target Announced at $151 - GuruFocus

May 22, 2026

May 22, 2026

Revolution Medicines stock hits all-time high at 155.72 USD - Investing.com

May 22, 2026

May 22, 2026

Bernstein Initiates Revolution Medicines at Market Perform - Moomoo

May 22, 2026

May 22, 2026

1RVMD.MI Technical Analysis | Trend, Signals & Chart Patterns | REVOLUTION MEDICINES INC (BIT:1RVMD) - ChartMill

May 22, 2026

May 22, 2026

Revolution Medicines to host webcast on phase 3 trial results By Investing.com - Investing.com Australia

May 22, 2026

May 21, 2026

RVMD reports wider-than-expected loss in Q1, raises '26 expense view - MSN

May 21, 2026

May 21, 2026

Revolution Medicines to host webcast on phase 3 trial results - Investing.com UK

May 21, 2026

May 21, 2026

Bernstein initiates Revolution stock coverage at Market Perform on valuation - Investing.com UK

May 21, 2026

May 21, 2026

Revolution Medicines (RVMD) Coverage Initiated with Market Perfo - GuruFocus

May 21, 2026

May 21, 2026

Revolution Medicines to Host Investor Conference Call on Positive RASolute 302 Results Following 2026 ASCO Presentation - The Manila Times

May 21, 2026

May 21, 2026

Pancreatic cancer trial results prompt May 31 Revolution Medicines call - Stock Titan

May 21, 2026

May 21, 2026

symbol__ Stock Quote Price and Forecast - CNN

May 21, 2026

May 21, 2026

Eagle Health Investments LP Makes New $9.23 Million Investment in Revolution Medicines, Inc. $RVMD - MarketBeat

May 21, 2026

May 21, 2026

Is Daraxonrasib’s Phase 3 Pancreatic Cancer Data And EQRx Deal Altering The Investment Case For Revolution Medicines (RVMD)? - Yahoo Finance

May 21, 2026

May 20, 2026

Revolution Medicines Recasts RAS Story With Phase 3 Win And New Firepower - simplywall.st

May 20, 2026

May 20, 2026

Profund Advisors LLC Has $2.15 Million Stock Holdings in Revolution Medicines, Inc. $RVMD - MarketBeat

May 20, 2026

May 20, 2026

Needham Keeps Buy Rating on Revolution Medicines (RVMD) Despite Wider Loss - Insider Monkey

May 20, 2026

May 19, 2026

ERASCA INVESTOR ALERT: Bragar Eagel & Squire, P.C. is Investigating Erasca, Inc. on Behalf of Erasca Stockholders and Encourages Investors to Contact the Firm - GlobeNewswire Inc.

May 19, 2026

May 18, 2026

Revolution Medicines, Inc.Common Stock (NQ: RVMD - FinancialContent

May 18, 2026

May 18, 2026

Truist assumes Revolution stock coverage with buy on cancer drug potential - Investing.com

May 18, 2026

May 18, 2026

Truist Financial Initiates Revolution Medicines(RVMD.US) With Buy Rating, Announces Target Price $179 - Moomoo

May 18, 2026

May 18, 2026

Revolution Medicines, Inc. (RVMD) Stock Analysis: Biotech Heavyweight with 24% Potential Upside - DirectorsTalk Interviews

May 18, 2026

May 17, 2026

JP Morgan Maintains Revolution Medicines (RVMD) Overweight Recommendation - MSN

May 17, 2026

May 17, 2026

Assessing Revolution Medicines (RVMD) Valuation After A Powerful Multi Year Shareholder Return Run - Yahoo Finance

May 17, 2026

May 16, 2026

Cancer Centers Race To Access Revolution Medicines' Pancreatic Cancer Treatment: Report - Sahm

May 16, 2026

May 15, 2026

Janus Henderson Group reports stake in Revolution Medicines (RVMD) — 9.77M shares - Stock Titan

May 15, 2026

May 15, 2026

Why (RVMD) Price Action Is Critical for Tactical Trading - Stock Traders Daily

May 15, 2026

May 15, 2026

AIHC Capital Management Ltd Acquires New Holdings in Revolution Medicines, Inc. $RVMD - MarketBeat

May 15, 2026

May 15, 2026

Piper Sandler Initiates Coverage of Revolution Medicines (RVMD) with Overweight Recommendation - MSN

May 15, 2026

May 15, 2026

US cancer clinics scramble to get experimental Revolution Medicines pancreatic cancer drug - Reuters

May 15, 2026

May 14, 2026

Revolution Medicines (RVMD) down 8.8% since last earnings report: Can it rebound? - MSN

May 14, 2026

May 14, 2026

Revolution Medicines Advances Daraxonrasib Into Phase 3 Pancreatic Cancer Trial, Raising Long-Term Upside Potential - TipRanks

May 14, 2026

May 14, 2026

RVMD Stock Price, Quote & Chart | REVOLUTION MEDICINES INC (NASDAQ:RVMD) - ChartMill

May 14, 2026

May 13, 2026

Revolution Medicines Warrants: Balancing Dilution Risk and Potential Worthlessness Ahead of 2026 Expiry - TipRanks

May 13, 2026

May 12, 2026

How an ‘Impossible’ Idea Led to a Pancreatic Cancer Breakthrough - The New York Times

May 12, 2026

May 11, 2026

Revolution Medicines outlines $1.7B-$1.8B in 2026 GAAP operating expenses while expanding RASolve 301 to 590 patients - MSN

May 11, 2026

May 11, 2026

Q2 EPS Forecast for Revolution Medicines Lowered by Analyst - MarketBeat

May 11, 2026

May 10, 2026

Revolution Medicines (RVMD) Receives FDA’s “Safe to Proceed” Letter for Daraxonrasib - Insider Monkey

May 10, 2026

May 10, 2026

Is It Too Late To Consider Revolution Medicines (RVMD) After A 240% One Year Surge? - Yahoo Finance

May 10, 2026